Inhibition of cardiovascular low‐Km cAMP phosphodiesterase activity by medorinone
- 1 January 1990
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 21 (2) , 93-104
- https://doi.org/10.1002/ddr.430210203
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Cardiovascular effects of medorinone in ?-adrenoreceptor-blocked and non-blocked anesthetized dogsDrug Development Research, 1990
- Activation of the cAMP system by medorinone correlates with positive inotropy or vasorelaxationDrug Development Research, 1990
- Biochemical aspects of inhibition of cardiovascular low (Km) cyclic adenosine monophosphate phosphodiesteraseThe American Journal of Cardiology, 1989
- Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and airway smooth muscleEuropean Journal of Pharmacology, 1988
- Subclasses of cyclic AMP-specific phosphodiesterase in left ventricular muscle and their involvement in regulating myocardial contractility.Circulation Research, 1987
- Studies aimed at elucidating the mechanism of action of CI-914, a new cardiotonic agentEuropean Journal of Pharmacology, 1985
- Cyclic Nucleotides and Regulation of Vascular Smooth MuscleJournal of Cardiovascular Pharmacology, 1984
- Studies on the Mechanism of the Cardiotonic Activity of MDL 19205Journal of Cardiovascular Pharmacology, 1984
- Cyclic nucleotides and cardiac function.Circulation Research, 1979
- The purification of cardiac myofibrils with Triton X-100Biochimica et Biophysica Acta (BBA) - Bioenergetics, 1971